• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home Health

Breast cancer overdiagnosis rates not as high as estimated previously

byDavid XiangandHarsh Shah
March 17, 2022
in Health, Imaging and Intervention, Oncology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. About 1 in 7 cases of screen-detected cancer is overdiagnosed in the US population.

2. The rate of breast cancer overdiagnosis in US population-based mammography screening was not as high as suggested by previous excess-incidence studies.

Evidence Rating Level: 1 (Excellent)

Study Rundown: The US Preventive Services Task Force cites overdiagnosis as one of the major potential harms associated with mammography screening because of the burden and adverse effects of unnecessary treatments. However, the risk for breast cancer overdiagnosis remains unclear, with estimates ranging from 0% to 54%, as many factors such as overdiagnosis definitions, study settings, and estimation methods influence the rate. Therefore, there is a gap in knowledge as to estimating the rate of breast cancer overdiagnosis in contemporary mammography practice accounting for the detection of nonprogressive cancer. This study found that based on the US population, breast cancer overdiagnosis was unlikely to be as high as suggested by previous excess-incidence studies. This study was limited by including only those women who had their first screening examination within the Breast Cancer Surveillance Consortium (BCSC), as well as the potential for model misspecification. Nevertheless, these study’s findings are significant, as they demonstrate that the rate of overdiagnosis of breast cancer is not as high as previously estimated, which helps clarify the risk for such events in contemporary screening practice.

Click to read the study in AIM

Relevant Reading: Reducing the Burden of Overdiagnosis in Breast Cancer Screening and Beyond

In-Depth [population cohort study]: This population cohort study followed a cohort of women who received 1 or more screening mammograms at a BCSC facility between 2000 and 2018. This included 35,986 women, 82,677 mammograms, and 718 breast cancer diagnoses. Overdiagnosis was estimated through Bayesian inference. Patients who were aged 50 to 74 years and had the first screen at a BCSC facility were eligible for the study. Patients who had received a mammogram or breast cancer diagnosis before their first mammogram in the BCSC registry were excluded from the study. The primary outcome was screening mammograms and screen-detected or interval breast cancer. Outcomes in the primary analysis were conducted via Bayesian inference of the natural history of breast cancer using individual screening and diagnosis records, combined with fitted natural history models with life-table data to predict the rate of overdiagnosis under biennial screening. Based on the analysis, through biennial screening, 15.4% (95% uncertainty interval [UI], 9.4% to 26.5%) of screen-detected cancers were estimated to be overdiagnosed. Of these cases, 6.1% (95% UI, 0.2% to 20.1%) were due to detecting indolent preclinical cancer and 9.3% (95% UI, 5.5% to 13.5%) were due to detecting progressive preclinical cancer in patients who would have died of an unrelated cause before the breast cancer clinical diagnosis. Furthermore, doubling the screening frequency from biennial to annual resulted in an overdiagnosis rate of 14.6% (95% prediction interval, 9.4% to 23.9%) with patterns similar to those under biennial screening. Overall, this study demonstrated that breast cancer overdiagnosis is unlikely to be as high as previously suggested by excess-incidence studies based on the US population.

RELATED REPORTS

Combination therapy with alisterib and fulvestrant may be clinically advantageous in the treatment of endocrine-resistant advanced breast cancer

Liver enzymes elevated at 6 months prior to breast cancer liver metastasis detection

#StudyGraphics: Adjuvant abemaciclib improves survival in patients with hormone receptor-positive early breast cancer

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancerbreast cancer screeningmammographyoverdiagnosis
Previous Post

Ribociclib plus letrozole provides greater overall survival benefit advanced breast cancer

Next Post

Overdoses in youth with benzodiazepine and stimulant prescriptions

RelatedReports

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Chronic Disease

Combination therapy with alisterib and fulvestrant may be clinically advantageous in the treatment of endocrine-resistant advanced breast cancer

March 12, 2023
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Gastroenterology

Liver enzymes elevated at 6 months prior to breast cancer liver metastasis detection

March 8, 2023
#StudyGraphics: Adjuvant abemaciclib improves survival in patients  with hormone receptor-positive early breast cancer
StudyGraphics

#StudyGraphics: Adjuvant abemaciclib improves survival in patients with hormone receptor-positive early breast cancer

March 8, 2023
Adjunctive TMP-SMX (Bactrim) associated with higher clinical cure rates for cutaneous abscesses
Obstetrics

Low household income associated with worse outcomes for estrogen receptor-positive breast cancer

February 28, 2023
Next Post
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Overdoses in youth with benzodiazepine and stimulant prescriptions

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

Large spike in drug use-associated infective endocarditis linked with opioid epidemic

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stroke may be associated with sleep disturbances in adults
  • Transcarotid artery revascularization not associated with a significant difference in 30-day risk of stroke, death and myocardial infarction compared to carotid endarterectomy
  • Drinking characteristics in adolescence predict alcohol behaviors in early adulthood
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options